Keywords:
сахарный диабет 2 типа, хроническая сердечная недостаточность, генетические полиморфизмы, кардиомиопатия, инсулинорезистентность, воспаление, митохондриальные гены, натрийуретические пептиды, адренорецепторы, GDF-15, персонализированная медицина.References
1. Adela R., Banerjee S.K. GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective // Journal of Diabetes Research. – 2015. – Vol. 2015. – Article 490842.
2. Dronavalli S., Duka I., Bakris G.L. The pathogenesis of diabetic nephropathy // Nature Clinical Practice Endocrinology & Metabolism. – 2008. – Vol. 4, № 8. – P. 444–452.
3. Huang J., Li C., Song Y. et al. ADRB2 polymorphism Arg16Gly modifies the natural outcome of heart failure and dictates therapeutic response to β-blockers in patients with heart failure // Cell Discovery. – 2018. – Vol. 4. – Article 57.
4. McMurray J.J.V., Gerstein H.C., Holman R.R., Pfeffer M.A. Diabetes, chronic heart failure, and cardiovascular risk: epidemiology and pathophysiology // Lancet Diabetes & Endocrinology. – 2019. – Vol. 7, № 8. – P. 630–639.
5. Newton-Cheh C., Larson M.G., Vasan R.S. et al. Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure // Nature Genetics. – 2009. – Vol. 41, № 3. – P. 348–353.
6. Pfeffer M.A., Shah A.M., Borlaug B.A. Heart Failure With Preserved Ejection Fraction In Perspective // Circulation Research. – 2019. – Vol. 124, № 11. – P. 1598–1617.
7. Smith N.L., Felix J.F., Morrison A.C. et al. Genetic predictors of cardiovascular disease risk in type 2 diabetes // Current Diabetes Reports. – 2018.
8. Tabish A.M., Azzimato V., Alexiadis A., Buyandelger B., Knöll R. Genetic epidemiology of titin-truncating variants in the etiology of dilated cardiomyopathy // Biophysical Reviews. – 2017. – Vol. 9, № 3. – P. 207–223.
9. Zeggini E., McCarthy M.I. Genetic determinants of type 2 diabetes // Clinical Medicine (London). – 2017. – Vol. 17, № 6. – P. 545–549.
